B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA)

MLA

Gilead Sciences, et al. B-Cell Malignancies Treated with Targeted Drugs and SARS-CoV-2 Infection: A European Hematology Association Survey (EPICOVIDEHA). 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1373159618&authtype=sso&custid=ns315887.

APA

Gilead Sciences, Infante, M.-S., Salmanton-García, J., Ana Fernández-Cruz, Marchesi, F., Jakšić, O., Weinbergerová, B., Duarte, R. F., Itri, F., Valković, T., Szotkovski, T., Busca, A., Guidetti, A., Glenthøj, A., Collins, G. P., Bonuomo, V., Sili, U., Cengiz Seval, G., Machado, M., … Pagano, L. (2022). B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA).

Chicago

Gilead Sciences, María-Stefania Infante, Jon Salmanton-García, Ana Fernández-Cruz, Francesco Marchesi, Ozren Jakšić, Barbora Weinbergerová, et al. 2022. “B-Cell Malignancies Treated with Targeted Drugs and SARS-CoV-2 Infection: A European Hematology Association Survey (EPICOVIDEHA).” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1373159618&authtype=sso&custid=ns315887.